 Now, despite the Federal Reserve Bank of New York reporting Americans' expectation for inflation lower again in June for the second month in a row, investors are worried about the new earnings season beginning this week. Also about inflation and congressional testimony from the head of the Federal Reserve and what his thoughts are on interest rates. That's this week. The big gainer, the specialty drug maker Morphic.